Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amelioration of Claustrophobia and Disruptive Patient Motion in MRI Imaging (Phase 2 Randomized Training of Sites)

NCT02427737 is registered in ClinicalTrials.gov with Hypnalgesics, LLC as lead sponsor.

NCT NCT02427737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02427737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amelioration of Claustrophobia and Disruptive Patient Motion in MRI Imaging (Phase 2 Randomized Training of Sites)
Lead sponsor
Hypnalgesics, LLC
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
July 31, 2017
Enrollment
12 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

claustrophobia, complication of diagnostic procedure